| RS2147858567 |
TEX11
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS2147859144 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147859764 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147859836 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147859879 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147860367 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147863799 |
SMG8
|
Health Risk |
Pathogenic |
Alzahrani-Kuwahara syndrome, Alzahrani-Kuwahara syndrome |
| RS2147863904 |
SMG8
|
Health Risk |
Pathogenic |
Alzahrani-Kuwahara syndrome, Alzahrani-Kuwahara syndrome |
| RS2147864743 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2147865360 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147865476 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147865567 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147865582 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147865584 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147865597 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147865716 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147865795 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147865884 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147865920 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147869121 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147869202 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147869275 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147869403 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147869490 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Nonpapillary renal cell carcinoma |
| RS2147870528 |
SLC16A2
|
Health Risk |
Likely pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS2147870607 |
SLC16A2
|
Health Risk |
Likely pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS2147870613 |
SLC16A2
|
Health Risk |
Pathogenic |
— |
| RS2147870614 |
SLC16A2
|
Health Risk |
Pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS2147871007 |
SLC16A2
|
Health Risk |
Likely pathogenic |
— |
| RS2147871831 |
SLC16A2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2147871837 |
SLC16A2
|
Health Risk |
Likely pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS2147871878 |
SLC16A2
|
Health Risk |
Likely pathogenic |
Allan-Herndon-Dudley syndrome, Spastic paraplegia |
| RS2147871919 |
SLC16A2
|
Health Risk |
Likely pathogenic |
Allan-Herndon-Dudley syndrome, Allan-Herndon-Dudley syndrome |
| RS2147872098 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147872148 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147872245 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147872254 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147872291 |
COL4A5
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2147872357 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147872358 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147873472 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147881303 |
SYP
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147882650 |
SYP
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 96 |
| RS2147884161 |
SYP
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 96 |
| RS2147891252 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147892965 |
DLG3
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 90 |
| RS2147894739 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147894816 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147895629 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 2A, Congenital stationary night blindness 2A |
| RS2147895764 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147895770 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147896131 |
CACNA1F
|
Health Risk |
Likely pathogenic |
CACNA1F-related disorder, CACNA1F-related disorder |
| RS2147897025 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147897090 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Aland island eye disease, Aland island eye disease |
| RS2147900556 |
CACNA1F
|
Health Risk |
Pathogenic |
Aland island eye disease, Aland island eye disease |
| RS2147900685 |
NLGN3
|
Health Risk |
Likely pathogenic |
Autism, susceptibility to |
| RS2147904608 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147904860 |
CACNA1F
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147905040 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147907396 |
BPTF
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS2147907436 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147907573 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147908102 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147908798 |
NLGN3
|
Health Risk |
Likely pathogenic |
Autism, susceptibility to |
| RS2147909115 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147909623 |
CACNA1F
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147909707 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147910114 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147910175 |
CACNA1F
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 3, X-linked cone-rod dystrophy 3 |
| RS2147910339 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147911186 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS2147911203 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147911225 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS2147911262 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147911265 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147911268 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147911364 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147911365 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147911367 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147911550 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147912005 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147912133 |
SYN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, X-linked 1 |
| RS2147912165 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147912333 |
SYN1
|
Health Risk |
Likely pathogenic |
Epilepsy, X-linked 1 |
| RS2147912440 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147912678 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147912740 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147913041 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Fumarase deficiency, Fumarase deficiency |
| RS2147913184 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147913263 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147913278 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147913317 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147913368 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS2147913407 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147913409 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147913419 |
SYN1
|
Health Risk |
Likely pathogenic |
Epilepsy, X-linked 1 |
| RS2147913449 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Familial cancer of breast |
| RS2147914878 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147914910 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147914951 |
FH
|
Health Risk |
Likely pathogenic |
— |